SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-025401
Filing Date
2023-09-07
Accepted
2023-09-07 16:30:15
Documents
14
Period of Report
2023-09-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230907_8k.htm   iXBRL 8-K 46288
2 EXHIBIT 4.3 ex_567728.htm EX-4.3 93734
  Complete submission text file 0001437749-23-025401.txt   287480

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arch-20230907.xsd EX-101.SCH 3408
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230907_def.xml EX-101.DEF 10352
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230907_lab.xml EX-101.LAB 13835
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230907_pre.xml EX-101.PRE 10347
8 EXTRACTED XBRL INSTANCE DOCUMENT arch20230907_8k_htm.xml XML 2322
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 231242636
SIC: 3841 Surgical & Medical Instruments & Apparatus